Terms defined in rule
3701:1-38-01 of the
Administrative Code shall have the same meaning when used in this chapter
except as set out herein unless otherwise specifically defined
elsewhere
The terms used in this chapter have
the same meaning as found in rule
3701:1-38-01 of the
Administrative Code, unless an alternative definition is provided in this rule
or in another rules of this chapter:
(A)
"Authorized
medical physicist" means an individual who:
"Associate radiation safety officer" means an individual
who:
(2)
Is currently
identified as an associate radiation safety officer for the types of use of
radioactive material for which the individual has been assigned duties and
tasks by the radiation safety officer on:
(a)
A specific
medical use license issued by the director, the United States nuclear
regulatory commission, or an agreement state; or
(b)
A medical use
permit issued by a United States nuclear regulatory commission master material
licensee.
(1) Meets the requirements in
paragraph (A) of rule
3701:1-58-19
and rule
3701:1-58-22
of the Administrative Code; or
(2) Is identified as an authorized
medical physicist or teletherapy physicist on:
(a) A specific medical use license
issued by the director, United States nuclear regulatory commission, or an
agreement state;
(b) A medical use permit issued by a
United States nuclear regulatory commission master material
licensee;
(c) A permit issued by a United
States nuclear regulatory commission or agreement state broad scope medical use
licensee; or
(d) A permit issued by a United
States nuclear regulatory commission master material license broad scope
medical use permittee.
(B)
"Authorized
medical physicist" means an individual who:
(1)
Meets the
requirements in paragraph (A) of rule
3701:1-58-19
and in rule
3701:1-58-22
of the Administrative Code; or
(2)
Is identified as
an authorized medical physicist or teletherapy physicist on:
(a)
A specific
medical use license issued by the director, the United States nuclear
regulatory commission, or an agreement state;
(b)
A medical use
permit issued by a United States nuclear regulatory commission master material
licensee;
(c)
A permit issued by a United States nuclear regulatory
commission or agreement state broad scope medical use licensee;
or
(d)
A permit issued by a United States nuclear regulatory
commission master material license broad scope medical use
permittee.
(B)
(C) "Authorized
nuclear pharmacist" means a pharmacist who:
(1) Meets the requirements in paragraph (A)
of rule
3701:1-58-20
and
in rule
3701:1-58-22
of the Administrative Code; or
(2)
Is identified as an authorized nuclear pharmacist on:
(a) A specific license issued by the
director,
the United States nuclear regulatory
commission, or an agreement state that authorizes medical use or the practice
of nuclear pharmacy;
(b) A permit
issued by a United States nuclear regulatory commission master material
licensee that authorizes medical use or the practice of nuclear
pharmacy;
(c) A permit issued by a
United States nuclear regulatory commission or agreement state broad scope
medical use licensee that authorizes medical use or the practice of nuclear
pharmacy; or
(d) A permit issued by
a United States nuclear regulatory commission master material license broad
scope medical use permittee that authorizes medical use or the practice of
nuclear pharmacy; or
(3)
Is identified as an authorized nuclear pharmacist by a commercial nuclear
pharmacy that has been authorized to identify authorized nuclear pharmacists;
or
(4) Is designated as an
authorized nuclear pharmacist in accordance with rule
3701:1-46-43
of the Administrative Code.
(C)
(D) "Authorized user"
means a physician, dentist, or podiatrist who:
(2)
Is identified as an authorized user on:
(a) A
license issued by the director,
the United States
nuclear regulatory commission, or an agreement state that authorizes the
medical use of radioactive material;
(b) A permit issued by a United States
nuclear regulatory commission master material licensee that is authorized to
permit the medical use of radioactive material;
(c) A permit issued by a United States
nuclear regulatory commission or agreement state specific licensee of broad
scope that is authorized to permit the medical use of radioactive material;
or
(d) A permit issued by a United
States nuclear regulatory commission master material license broad scope
permittee that is authorized to permit the medical use of radioactive
material.
(D)
(E) "Brachytherapy"
means a method of radiation therapy in which sources are used to deliver a
radiation dose at a distance of up to a few centimeters by surface,
intracavitary, intraluminal, or interstitial application.
(E)
(F)
"Brachytherapy source" means a radioactive source or a manufacturer-assembled
source train or a combination of these sources that is designed to deliver a
therapeutic dose within a distance of a few centimeters.
(F)
(G)
"Client's address" means the area of use or a temporary job site, as defined in
this rule, for the purpose of providing mobile medical service in accordance
with rule
3701:1-58-31
of the Administrative Code.
(G)
(H) "High dose-rate
remote afterloader," as used in this chapter, means a brachytherapy device that
remotely delivers a dose rate in excess of twelve gray (one thousand two
hundred rads) per hour at the point or surface where the dose is
prescribed.
(H)
(I) "Low dose-rate remote afterloader," as used in
this chapter, means a brachytherapy device that remotely delivers a dose rate
of less than or equal to two gray (two hundred rads) per hour at the point or
surface where the dose is prescribed.
(I)
(J) "Manual
brachytherapy," as used in this chapter, means a type of brachytherapy in which
the brachytherapy sources, such as seeds or ribbons are manually placed
topically on or inserted either into the body cavities that are in close
proximity to a treatment site or directly into the tissue volume.
(J)
(K)
"Medical event" means an event that meets the criteria in paragraph (A) or (B)
of rule
3701:1-58-101
of the Administrative Code.
(K)
(L) "Medium dose-rate
remote afterloader," as used in this chapter, means a brachytherapy device that
remotely delivers a dose rate of greater than two gray (two hundred rads) per
hour, but less than or equal to twelve gray (one thousand two hundred rads) per
hour at the point or surface where the dose is prescribed.
(L)
(M)
"Mobile medical service" means the transportation of radioactive material to
and its medical use at the client's address.
(N)
"Ophthalmic
physicist" means an individual who:
(1)
Meets the requirements in paragraph (A)(2) of rule
3701:1-58-49 and in rule
3701:1-58-22
of the Administrative Code; and
(2)
Is identified as
an ophthalmic physicist on a:
(a)
Specific medical use license issued by the director,the
United States nuclear regulatory commission, or an agreement
state;
(b)
Permit issued by a United States nuclear regulatory
commission or agreement state broad scope medical use licensee;
(c)
Medical use
permit issued by a United States nuclear regulatory commission master material
licensee; or
(d)
Permit issued by a United States nuclear regulatory
commission master material licensee broad scope medical use
permittee.
(M)
(O) "Output" means the
exposure rate, dose rate, or a quantity related in a known manner to these
rates from a brachytherapy source or a teletherapy, remote afterloader, or
gamma stereotactic radiosurgery unit for a specified set of exposure
conditions.
(N)
(P) "Patient intervention" means actions by the
patient or human research subject, whether intentional or unintentional, such
as dislodging or removing treatment devices or prematurely terminating the
administration.
(O)
(Q) "Personal Representative" means:
(1) A person who has authority to act on
behalf of an individual who is an adult or an emancipated minor in making
decisions related to health care, or
(2) A parent, guardian, or other person
acting in loco parentis who has authority to act on behalf of an individual who
is an unemancipated minor in making decisions related to health care.
(P)
(R) "Preceptor" means an individual who provides,
directs, or verifies the training and experience required for an individual to
become an authorized user, an authorized medical physicist, an authorized
nuclear pharmacist,
or a radiation safety
officer
, or an associate radiation safety
officer.
(Q)
(S) "Prescribed dosage" means the specified activity
or range of activity of unsealed radioactive material as documented:
(1) In a written directive; or
(2) In accordance with the directions of the
authorized user for procedures performed pursuant to rules
3701:1-58-32
and
3701:1-58-34
of the Administrative Code.
(R)
(T) "Prescribed dose"
means:
(1) For gamma stereotactic
radiosurgery, the total dose as documented in the written directive;
(2) For teletherapy, the total dose and dose
per fraction as documented in the written directive;
(3) For manual brachytherapy, either the
total source strength and exposure time or the total dose, as documented in the
written directive; or
(4) For
remote brachytherapy afterloaders, the total dose and dose per fraction as
documented in the written directive.
(S)
(U) "Pulsed dose-rate
remote afterloader," as used in this chapter, means a special type of remote
afterloading brachytherapy device that uses a single source capable of
delivering dose rates in the "high dose-rate'' range, but:
(1) Is approximately one-tenth of the
activity of typical high dose-rate remote afterloader sources; and
(2) Is used to simulate the radiobiology of a
low dose-rate treatment by inserting the source for a given fraction of each
hour.
(T)
(V) "Radiation safety officer," as used in this
chapter, means an individual who:
(1) Meets
the requirements in paragraph (A) or (C)(1) of rule
3701:1-58-18
and
in rule
3701:1-58-22
of the Administrative Code, or
(2)
Is identified as a radiation safety officer on:
(a) A specific medical use license issued by
the director,
the United States nuclear
regulatory commission, or an agreement state that authorizes the medical use of
radioactive material; or
(b) A
medical use permit issued by a United States nuclear regulatory commission
master material licensee.
(U)
(W) "Stereotactic
radiosurgery" means the use of external radiation in conjunction with a
stereotactic guidance device to very precisely deliver a therapeutic dose to a
tissue volume.
(V)
(X) "Structured educational program" means an
educational program designed to impart particular knowledge and practical
education through interrelated studies and supervised training.
(W)
(Y)
"Teletherapy," as used in this chapter, means a method of radiation therapy in
which collimated gamma rays are delivered at a distance from the patient or
human research subject.
(X)
(Z) "Teletherapy
Physicist" means the individual identified as the teletherapy physicist on a
radioactive material license issued by the state of Ohio.
(Y)
(AA)
"Temporary job site," as used in this chapter, means a location where mobile
medical services are conducted other than those location(s) of use authorized
on the license.
(Z)
(BB) "Therapeutic dosage" means a dosage of unsealed
radioactive material that is intended to deliver a radiation dose to a patient
or human research subject for palliative or curative treatment.
(AA)
(CC)
"Therapeutic dose" means a radiation dose delivered from a source containing
radioactive material to a patient or human research subject for palliative or
curative treatment.
(BB)
(DD) "Treatment site" means the anatomical description
of the tissue intended to receive a radiation dose, as described in a written
directive.
(DD)
(FF) "Unit dosage"
means a dosage prepared for medical use for administration as a single dosage
to a patient or human research subject without any further manipulation of the
dosage after it is initially prepared.
(EE)
(GG) "Written
directive," as specified in rule
3701:1-58-15
of the Administrative Code, means an authorized user's written order for the
administration of radioactive material or radiation from radioactive material
to a specific patient or human research subject.